BRAF V600E

Clinical trials for BRAF V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E trials appear

Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 2

New pill combo shows promise for Hard-to-Treat lung cancer mutation

Disease control Ongoing

This phase 2 study tests two targeted drugs, encorafenib and binimetinib, in 119 people with advanced non-small cell lung cancer that has a specific BRAF V600E mutation. The goal is to see if the combination can shrink tumors and keep them from growing. Participants take the pill…

Matched conditions: BRAF V600E

Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

BRAF V600E

Get alerted when new BRAF V600E trials appear

New pill combo shows promise for Hard-to-Treat lung cancer mutation